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In the early zebraﬁsh embryo, a ventral to dorsal gradient of bone morphogenetic protein (BMP) activity
is established, which is essential for the speciﬁcation of cell fates along this axis. To visualise and
mechanistically determine how this BMP activity gradient forms, we have used a transgenic zebraﬁsh
line that expresses monomeric red ﬂuorescent protein (mRFP) under the control of well-characterised
BMP responsive elements. We demonstrate that mRFP expression in this line faithfully reports BMP and
GDF signalling at both early and late stages of development. Taking advantage of the unstable nature of
mRFP transcripts, we use in situ hybridisation to reveal the dynamic spatio-temporal pattern of BMP
activity and establish the timing and sequence of events that lead to the formation of the BMP activity
gradient. We show that the BMP transcriptional activity gradient is established between 30% and 40%
epiboly stages and that it is preceded by graded mRNA expression of the BMP ligands. Both Dharma and
FGF signalling contribute to graded bmp transcription during these early stages and it is subsequently
maintained through autocrine BMP signalling. We show that BMP2B protein is also expressed in a
gradient as early as blastula stages, but do not ﬁnd any evidence of diffusion of this BMP to generate the
BMP transcriptional activity gradient. Thus, in contrast to diffusion/transport-based models of BMP
gradient formation in Drosophila, our results indicate that the establishment of the BMP activity gradient
in early zebraﬁsh embryos is determined by graded expression of the BMP ligands.
& 2013 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
During the development of multicellular organisms, a recurrent
mechanism for tissue patterning is the formation of morphogen
gradients. The original deﬁnition of a morphogen is a molecule
produced at a localised source which then diffuses into the
surrounding tissue to provide positional information and specify
different cell fates in a dose-dependent manner (Wolpert, 2011).
Bone morphogenetic proteins (BMPs) have been described as
morphogens and BMP gradients have been documented in various
developing organisms such as the sea urchin, Drosophila, Xenopus,
zebraﬁsh, and mouse (Ramel and Hill, 2012). The best understood
models of BMP gradient formation are the Drosophila BMP activity
gradients. In the Drosophila embryo, the BMP gradient that is
required for the speciﬁcation of dorsal and lateral tissues involves
the redistribution of the BMP ligands within a uniform expression
domain (O'Connor et al., 2006). In the developing Drosophila wing,
a BMP gradient forms across the Anterior/Posterior (A/P) axis
which extends beyond the source of the BMP ligand Decapenta-
plegic (Dpp; BMP4 orthologue). It is still debated whether thisill).
-ND license.involves free diffusion, restricted diffusion, and/or transcytosis of
Dpp (Erickson, 2011; Kicheva and Gonzalez-Gaitan, 2008;
Schwank et al., 2011; Yan and Lin, 2009). Much less is understood
about how BMP gradients are formed in vertebrate embryos. There
is increasing evidence that the establishment of these gradients is
highly complex and ﬁnely regulated (Wolpert, 2011), and that
mechanisms operating in Drosophila are not sufﬁcient to explain
them. A prerequisite for studying gradients in early vertebrate
embryos is a sensitive molecular tool for directly visualising them.
The BMPs, along with the related growth and differentiation
factors (GDFs), constitute a subfamily of the transforming growth
factor β (TGF-β) superfamily (Schmierer and Hill, 2007). BMPs and
GDFs signal through heteromeric serine/threonine kinase receptor
complexes comprising type II and type I receptors (also called
ALKs). Ligand binding promotes phosphorylation and activation of
the type I receptor by the type II receptor, leading to phosphoryla-
tion of a subset of receptor-activated Smads (R-Smads) (Moustakas
and Heldin, 2009). Once activated, the R-Smads form heteromeric
complexes with Smad4, which accumulate in the nucleus and
regulate target gene transcription. Importantly, the Smads con-
stantly shuttle between the cytoplasm and the nucleus in both the
presence and absence of signalling and the levels of activated
complexes in the nucleus are determined by the relative activities
of the receptor kinases in the cytoplasm and a nuclear phosphatase.
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provides a sensing mechanism for receptor activity (Schmierer and
Hill, 2007). For many years, TGF-β superfamily signalling was divided
into two distinct branches with respect to the R-Smads: BMPs and
GDFs were thought to signal exclusively through Smad1, Smad5 and
Smad8, whilst TGF-β, Activin and Nodals signalled through Smad2 and
Smad3 (Schmierer and Hill, 2007). However, it is now established that
in most cell types TGF-β additionally robustly activates Smad1 and
Smad5 (Bharathy et al., 2008; Daly et al., 2008; Goumans et al., 2002;
Liu et al., 2009; Wrighton et al., 2009). Hence, monitoring the
phosphorylation status of a particular R-Smad is not a reliable way
to discriminate signalling by different ligands. A more speciﬁc method
is to exploit reporter plasmids with binding sites for transcription
factors speciﬁcally activated by the pathway in question. For BMP/GDF
pathways, such a reporter was generated in which BMP responsive
elements (BREs) from the mouse Id1 enhancer, which bind phos-
phorylated Smad1/5–Smad4 complexes, drive luciferase expression
(Korchynskyi and ten Dijke, 2002). Most importantly, this BRE-
luciferase reporter exclusively responds to BMP/GDF signals and not
to TGF-β signals, despite the latter's ability to phosphorylate and
activate Smad1/5 (Daly et al., 2008; Gronroos et al., 2012; Liu et al.,
2009). We have recently generated a ﬂuorescent reporter transgenic
zebraﬁsh line using a modiﬁed version of this BRE-luciferase reporter
(BRE-mRFP) (Wu et al., 2011).
In zebraﬁsh embryos, a BMP activity gradient that is stronger
ventrally during the blastula and gastrula stages is required to
pattern the embryo along its dorsal/ventral (D/V) axis. The
existence of a BMP activity gradient is evident when monitoring
the expression of BMP target genes during gastrulation, such as
the bmp ligands themselves or the ventral ectoderm markers gata2
and ΔNP63 (Bakkers et al., 2002; Nguyen et al., 1998). The ﬁrst
direct visualisation of the zebraﬁsh BMP activity gradient was
obtained using anti-phosphorylated Smad1/5 (p-Smad1/5) immu-
nostaining (Tucker et al., 2008). This study concluded that a
ventral to dorsal gradient of nuclear p-Smad1/5 is set up between
4.75 h and 5 h post-fertilisation (hpf; 30–40% epiboly stages).
However, it is not known if the newly established BMP activity
gradient (as detected with p-Smad1/5) is also reﬂected in tran-
scriptional output as early as 30–40% epiboly, nor how it is formed.
Here we exploit our BRE-mRFP transgenic reporter line to
determine the mechanism by which the ventral to dorsal BMP
activity gradient is established. We ﬁrst deﬁnitively prove that mRFP
expression faithfully reports BMP and GDF signalling at both early
and late stages of development. Then, taking advantage of the
unstable nature of mRFP mRNA and the sensitivity of its detection,
we readily visualise the ventral to dorsal BMP transcriptional activity
gradient that is generated during blastula stages, showing it is
established by the 40% epiboly stage. We demonstrate using single
and double in situ hybridisation (ISH) that the graded BMP tran-
scriptional activity occurs in a pre-established domain of graded bmp
ligand transcripts. Using anti-BMP2B antibody staining, we also show
that graded bmp ligand transcription results in graded protein
expression. Moreover, in contrast to the mechanisms of BMP gradient
formation in Drosophila, our results provide no evidence for diffusion
or re-distribution of the BMP ligands during BMP gradient formation.
Finally, we deﬁne the sequence of signalling events that lead to
graded bmp transcription to generate a robust BMP activity gradient.Materials and methods
Fish maintenance, screening, strains and crosses
The zebraﬁsh colony was maintained as described (Westerﬁeld,
2000). Founders for the BRE-mRFP transgene (20% of F0 screened,
n¼49) were identiﬁed by crossing injected adult zebraﬁsh to wild-type and screening their progeny for mRFP ﬂuorescence at 24 hpf.
Experiments described here used F2, F3, or F4 progeny of ﬁve
different founders. The swrTA72A allele is a strong loss-of-function
allele corresponding to an ENU-induced point mutation in the
zebraﬁsh bmp2b termination codon (Kishimoto et al., 1997).
Plasmids, mRNAs, morpholinos and injections
The mRFP ORF was ampliﬁed from pcDNA-mRFP-N and cloned
into pGL3-BRE-luciferase (Korchynskyi and ten Dijke, 2002). BRE-
mRFP was then ampliﬁed from pGL3-BRE-mRFP and cloned into
pT2KXIGΔin. To generate the BRE-mRFP transgenic line the
pT2KXIGΔin-BRE-mRFP plasmid DNA (20 ng/μl) was co-injected
with transposase mRNA (25 ng/μl) as described (Kawakami et al.,
2004; Urasaki et al., 2006). The noggin1 and chordin ORFs were
ampliﬁed from mid-gastrulation stage cDNA and cloned into
pGEM-T and pCS2þ , respectively. The following mRNAs were
injected: CA-alk8 (7.5 ng/μl) (Bauer et al., 2001), bmp2b (50 ng/μl)
(Wu et al., 2011), chordin (320 ng/μl), membrane mRFP (50 ng/μl)
(Kieserman and Wallingford, 2009) and cherry H2B (80 ng/μl)
(Woolner and Papalopulu, 2012). The following MOs (Genetools,
LLC) were used: dharma (Shih et al., 2010), chordin (Nasevicius and
Ekker, 2000), gdf6a (French et al., 2009), bmp2b (Imai and Talbot,
2001) and bmp4 (Chocron et al., 2007). All MOs were injected at
6 ng/nl except the gdf6A and bmp2b MOs which were at 3 ng/nl. A
volume of approximately 2.5 nl of DNA, mRNA and/or MO was
injected per embryo.
In situ hybridisation, immunoﬂuorescence, and movies
The following antisense probes were used: mRFP (Wu et al.,
2011), dharma (Koos and Ho, 1998), noggin1, chordin (Miller-
Bertoglio et al., 1997), goosecoid (Stachel et al., 1993), bmp2b
(Kishimoto et al., 1997), bmp4 (Ramel, 2005), and bmp7a (Schmid
et al., 2000). The standard ISH protocol was essentially as
described (Jowett, 2001) with the addition of 5% dextran sulphate
to the hybridisation buffer (Lauter et al., 2011a). The double
ﬂuorescent ISH (DFISH) using DIG- and DNP-labelled probes and
revealed with ﬂuorescein tyramide and Fast Blue substrates was
modiﬁed from Lauter et al. (2011b) (detailed protocol available
upon request). For p-Smad1/5 (Cell Signalling 9511, 1:100) immu-
noﬂuorescence (IF), the protocol was as described (Tucker et al.,
2008). The BMP2B (Tebu-Bio 55707, 1:500) and pMAPK (Sigma
M8159, 1:500) IF protocols required an antigen retrieval step
(Inoue and Wittbrodt, 2011). For ISH combined with IF, ISH was
performed ﬁrst. After ISH substrate development (Cy5 tyramide),
embryos were washed in 1X PBS to stop the colourimetric
reaction, then immersed in IF blocking solution before proceeding
with IF. Embryos that had undergone colourimetric ISH were
equilibrated in 80% glycerol and photographed using a Leica
DFC420C camera mounted on a Leica MZ-FLIII dissecting micro-
scope. DFISH, immunostained and/or BRE-mRFP samples were
counterstained with DAPI (Roche 10 236 276 001), Hoechst
33342 (Invitrogen H1399), or DRAQ5 (Biostatus DR50200),
mounted in 0.8% low melt agarose (Sigma-Aldrich A9045) in
glass-bottom microwell dishes (MatTek P35G-1.5–14-C) and
imaged using a Zeiss LSM710 inverted confocal microscope.
Movies were acquired using a Zeiss LSM710 inverted or a Zeiss
LSM700 upright confocal microscope and live embryos were
mounted in low-melt agarose in ﬁsh water supplemented with
anaesthetic. Supplementary movie 4 was obtained using a Nikon
ECLIPSE TE2000-E inverted wide ﬁeld microscope and an Andor
iXonEMþ DU-888 back-illuminated EMCCD scientiﬁc camera.
Images and movies were acquired and/or processed with the
following software packages: Leica Application Suite, Zeiss Zen,
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Photoshop.Protein preparation and Western blotting
Embryonic protein extracts were prepared as described (Wu
et al., 2011). The following antibodies were used: rabbit anti-mRFP
(Invitrogen R10367) (Fig. S3), mouse anti-mRFP (SignalChem R46-
61M-100) (Fig. S2), rabbit anti-pSmad2 (a mixture of Millipore
AB3849 and 04953), mouse anti-pMAPK (Sigma M8159), mouse
anti-Actin (Sigma 3853) and goat anti-MCM6 (Santa Cruz sc-
9843).Chemical inhibitor treatments
LDN-193189 (gift from Paul Yu), SU5402 (Calbiochem 572631),
and SB-505124 (Tocris Bioscience 3263) stocks were made in
DMSO. These inhibitors were diluted in ﬁsh water to obtain the
desired ﬁnal concentration. 8- to 16-cell stage embryos were
immersed in ﬁsh water supplemented with either DMSO (control)
or the chemical inhibitors.cleavage stage 
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Characterisation of mRFP expression in BRE-mRFP embryos
To study BMP transcriptional activity and gradient formation
during zebraﬁsh development, we used our previously generated
BRE-mRFP reporter transgenic line (Wu et al., 2011), employing
both ISH for mRFP and direct observation of mRFP ﬂuorescence in
this line to assess BMP/GDF activity.
To observe early BMP signalling, we visualised mRFP mRNA,
which gives a very sensitive and dynamic readout. mRFP RNA is
expressed ubiquitously in 8-cell stage embryos (Fig. 1A), suggest-
ing that some mRFP mRNA is maternally deposited. mRFP mRNA is
also ubiquitous during blastula stages before and after the onset of
zygotic transcription, at the 512-cell and sphere stages, respec-
tively (Fig. 1B). During gastrulation, mRFP transcripts are strongly
reduced dorsally and are enriched ventrally in both the mesoderm
and ectoderm, and thus transgenic embryos display a clear ventral
to dorsal BMP activity gradient (Fig. 1C). During somitogenesis,
mRFP expression is highly dynamic (Fig. 1D, S1). Most notably,
mRFP mRNA is detected in the newly formed somites, the devel-
oping eyes, tailbud and presomitic mesoderm, consistent with
studies implicating BMP activity in these tissues (Esterberg et al., stages
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Finally, at 28 hpf,mRFPmRNA is found in additional tissues such as
the pineal gland, the developing heart, and the pectoral ﬁn buds
(Fig. 1E).
In BRE-mRFP embryos, mRFP ﬂuorescence is only ﬁrst visible
around the 6-somite stage, when a strong signal is seen in the tail
bud and presomitic mesoderm (Fig. S2A). This delay in detection is
due to insufﬁcient mRFP protein being synthesised during gas-
trulation for direct mRFP ﬂuorescence visualisation, as full-length
mRFP protein is virtually undetectable before the 6-somite stage
using Western blotting (Fig. S2B). During somitogenesis, the
strongest mRFP protein expression domains are the tail bud and
the presomitic mesoderm (Fig. S2A; Videos S1,S2), thereby con-
ﬁrming the in situ results. Most notably, at 24 hpf, strong mRFP
ﬂuorescence is detected in the dorsal retina, the epiphysis/pineal
gland, the epidermis, the cloaca, and the somites (Fig S2A and
Video S3) (Alexander et al., 2011; Collery and Link, 2011; French
et al., 2009; Laux et al., 2011; Patterson et al., 2010; Pyati et al.,
2006; Row and Kimelman, 2009). In addition, mRFP ﬂuorescence
is found in the cells of the midbrain–hindbrain border and the
trigeminal ganglia (Fig. S2A) (data not shown). Finally, mRFP
ﬂuorescence is detected in the atrioventricular canal of 50 hpf
transgenic embryos (Video S4), consistent with reported BMP
activity during mammalian early heart valve formation in the
BRE-GFP transgenic mouse (Monteiro et al., 2008).Video S4. Supplementary material related to this article can be found online at
http://dx.doi.org/10.1016/j.ydbio.2013.03.003.The BRE-mRFP transgenic zebraﬁsh is a bona ﬁde in vivo reporter
for BMP/GDF activity.
To establish unequivocally that mRFP expression reﬂects BMP/
GDF signalling, we manipulated BMP signalling at different times
during embryogenesis and assessed its effect on mRFP mRNA or
protein levels.Video S1. Supplementary material related to this article can be found online at
http://dx.doi.org/10.1016/j.ydbio.2013.03.003.
Video S2. Supplementary material related to this article can be found online at
http://dx.doi.org/10.1016/j.ydbio.2013.03.003.Stimulation of BMP signalling using overexpression of BMP2B
(a zygotic BMP ligand) (Nguyen et al., 1998) and the constitutively-
active BMP receptor CA-ALK8 (Bauer et al., 2001) or knockdown of
the BMP inhibitor Chordin (Schulte-Merker et al., 1997) resulted in
increased mRFP expression and expansion of the mRFP domain to
the dorsal side (Fig. 2A). Conversely, overexpression of Chordin
and the BMP antagonist Noggin (Zimmerman et al., 1996) com-
pletely abolished mRFP expression at 70–80% epiboly (Fig. 2A) (Wu
et al., 2011). Thus, changes in BMP activity are reﬂected in mRFP
expression along the D/V axis of the gastrulating embryo.
We also used a genetic approach to inhibit zygotic BMP activity,
investigating mRFP expression in a bmp2b-deﬁcient background
(Fig. 2B). At 70% epiboly, mRFP expression is strongly reduced in
homozygous swrTA72A (bmp2b−) embryos. From bud stage/early
somitogenesis, swrTA72A/swrTA72A embryos display a striking elon-
gated morphology (Mullins et al., 1996) unlike their swrTA72A/þ
and wild-type siblings. In 4-somite stage swrTA72A homozygous
embryos, mRFP expression is also strongly reduced. No difference
in mRFP expression between wild-type and swrTA72A heterozygous
siblings was detected (data not shown).
BMP activity is important at the end of gastrulation to specify
ventro-posterior fates, including formation of the cloaca, the
common opening of the urogenital and digestive tracts in zebra-
ﬁsh (Pyati et al., 2006, 2005). BMP4 is thought to be the critical
zygotic ligand for the speciﬁcation of cloacal fates as severe
bmp4ST72 homozygous zebraﬁsh mutants do not form a proper
cloaca (Stickney et al., 2007). Injection of a splice-blocking MO that
targets bmp4 mRNA (Chocron et al., 2007) results in severely
reduced mRFP expression in the cloaca of 28 hpf embryos, but
strikingly, has no effect on mRFP expression in the somites where
other BMP ligands must contribute to mRFP transcription (Fig. 2C).
The dorsal retina is another region of high mRFP expression
(Fig. 1E, S1, S2A). The GDF6A ligand is required for p-Smad1/5
activation in the dorsal retina (French et al., 2009), suggesting that
it might be the ligand responsible for mRFP expression in this
tissue. Injection of a gdf6a splice-blocking MO results in reduced
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ﬂuorescence in 26 hpf embryos (Fig. 2D), conﬁrming that the BRE-
mRFP transgenic line is also sensitive to changes in signalling by
ligands from the GDF subfamily. We were unable to detect any
effect of GDF6A knockdown on mRFP expression in other tissues
such as the somites, despite a recent study implicating GDF6A as a
factor required for somitic BMP activity during myogenesis
(Nguyen-Chi et al., 2012).
Finally, we decreased BMP/GDF signalling globally in
ﬁsh embryos using the chemical inhibitors Dorsomorphin and
LDN-193189, which target the type I BMP/GDF receptors, and lead
to a dorsalized phenotype (Cannon et al., 2010; Yu et al., 2008)
(Fig. S3). The chemical inhibitors are autoﬂuorescent, resulting in
considerable background when mRFP ﬂuorescence is visualised.
However, inhibition of mRFP expression is readily detected by
mRFP ISH and Western blotting for mRFP protein (Fig. S3).Taking all the results in this section together, we conclude that
mRFP expression in the BRE-mRFP transgenic embryos is an
accurate readout of dynamic BMP/GDF activity at all stages of
development examined.
The initial ventral to dorsal BMP transcriptional activity gradient is
established between 30% and 40% epiboly
The ability to visualise the ventral to dorsal BMP activity
gradient in the BRE-mRFP embryos by monitoring levels of mRFP
mRNA gave us a unique opportunity to investigate in detail how
this gradient forms.
From the 8-cell to the 30% epiboly stage, mRFP expression is
uniform (Fig. 3). The mRFP transcripts detected at the 8-, 256-, and
512-cell stage must be deposited maternally. In contrast, speciﬁc
nuclear p-Smad1/5 staining is only apparent from the 512-cell
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signalling initially (Goutel et al., 2000; Sidi et al., 2003), then as a
result of zygotic BMP signalling. At 40% epiboly, mRFP mRNA is
clearly enriched ventrally and expressed in a graded fashion in
BRE-mRFP embryos (Fig. 3). Comparison of the p-Smad1/5 staining
with the mRFP expression pattern revealed that decrease of
p-Smad1/5 from the dorsal side at 30% epiboly fractionally pre-
ceded loss of mRFP expression (Fig. 3). Hence, the BMP transcrip-
tional activity gradient (mRFP) is established between 30% and 40%
epiboly and occurs minutes after ventral enrichment of p-Smad1/
5. Notably, clearance of mRFP transcripts dorsally occurs in a very
short time frame (~20 min), conﬁrming that the mRFP mRNA half-
life is very short. Thus, observing mRFP transcripts at these early
stages provides a very dynamic readout of the BMP activity
gradient. Moreover, this comparative experiment shows that in
the case of early zebraﬁsh embryogenesis, it is also possible to use
p-Smad1/5 immunostaining as a readout for BMP pathway
activation.The BMP transcriptional activity gradient is established in a domain
of graded ligand transcription
Having determined exactly when the BMP activity gradient is
initially formed, we explored the mechanism underlying it. The
expression of zygotic bmp ligands is thought to be set up in two
key steps. First, after the mid-blastula transition (MBT; ~3.25 hpf),
a combination of the maternal BMP ligand GDF6A (possibly acting
through maternal ALK8 and Smad5) and the transcription factor
POU2 induce the ubiquitous expression of zygotic bmp2b and
bmp7a, which is shortly followed by bmp4 expression (Langdon
and Mullins, 2011). Second, the sequential action of dorsally-
expressed negative regulators contributes to the increase in
ventral expression of the BMP ligands. As early as sphere stage
(~4 hpf), Dharma, a transcriptional repressor that is expressed in
the dorsal-most blastomeres, directly represses bmp2b transcrip-
tion (Koos and Ho, 1999; Leung et al., 2003). Subsequently, a
combination of the dorsally-secreted BMP antagonists Noggin1
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M.-C. Ramel, C.S. Hill / Developmental Biology 378 (2013) 170–182176and Chordin acts to inhibit BMP signalling, with Chordin being
essential for BMP signalling repression (Dal-Pra et al., 2006). It is
not clear though when Chordin begins to confer its effect on BMP
ligand expression. In addition, there is evidence that the FGF
signalling pathway acts on the dorsal side to repress bmp tran-
scription (Furthauer et al., 2004). As a result of all these interac-
tions bmp ligand expression is clearly graded by the end of the
blastula stage (Furthauer et al., 2004; Sidi et al., 2003). However, it
is not known how the expression domain of the ligands relates to
the BMP activity gradient or to transcriptional output during these
critical stages.
To establish the sequence of events between dome stage and
40% epiboly, we compared the timing and pattern of mRFP mRNA
expression with that of the three zygotic BMP ligands: BMP2B andBMP7A, which act as obligate heterodimers (Little and Mullins,
2009), and BMP4. We also investigated expression at the level of
mRNA of the BMP antagonists expressed dorsally at blastula
stages, Chordin and Noggin1, the transcriptional repressor
Dharma, as well as dorsal FGF activity. At dome stage, dharma,
noggin1 and chordin are all expressed dorsally, and in the case of
noggin1 and chordin, expression increases at 30% and 40% epiboly
(Fig. 4A). We monitored FGF activity by immunostaining for di-
phosphorylated MAPK (pMAPK) (Jurynec and Grunwald, 2010),
and demonstrated that FGF is active at all stages examined, with
stronger activity detected on the dorsal side. This is especially
clear for pMAPK staining at dome stage (Fig. 4A). bmp2b and
bmp7a transcripts are expressed uniformly throughout most of the
embryo at dome stage, except on the most dorsal side, where a
M.-C. Ramel, C.S. Hill / Developmental Biology 378 (2013) 170–182 177clear gap in staining is visible (Fig. 4A). At 30% and 40% epiboly,
bmp2b and bmp7a show a clear asymmetric pattern, being stron-
ger on the ventral side and weaker on the dorsal side (Fig. 4A), in
agreement with reports that bmp2b and bmp7a are expressed
uniformly upon activation of zygotic transcription, then become
enriched ventrally (Hammerschmidt and Mullins, 2002; Leung
et al., 2003). bmp4 expression, in contrast, is detected ubiquitously
at dome stage (Fig. 4A) and only becomes ventrally enriched later
at 30% and 40% epiboly (Fig. 4A) (Langdon and Mullins, 2011).
Importantly, despite bmp ligands being expressed in a graded
manner from 30% epiboly, mRFP transcripts remain uniform in the
majority of embryos examined. In contrast, at 40% epiboly, the
gradient of mRFP, reﬂecting BMP transcriptional activity, was
evident, and strikingly, it appears very similar to the expression
patterns of the ligands (Fig. 4A).
To conﬁrm that the gradient of BMP ligand expression was the
same as the gradient of BMP activity, we used DFISH for bmp2b
and mRFP (Fig. 4B). As DFISH caused substantial autoﬂuorescence
from the yolk we visualised mRFP and bmp2b mRNAs at the
blastoderm margin only. As expected, bmp2b is expressed in a
ventral to dorsal gradient at both 30% and 40% epiboly and
consistent with the single ISH results (Figs 3 and 4A), mRFP is
only expressed in a gradient from 40% epiboly. DFISH shows a very
good overlap of bmp2b and mRFP transcripts at 40% epiboly,
conﬁrming that at this stage the BMP transcriptional activity
gradient occurs in a pre-established domain of graded ligand
transcription.
Graded bmp transcription results in a BMP protein gradient with little
or no transcriptional activity at a distance from BMP protein-
expressing cells
Our observations that the transcripts of the three major BMP
ligands are expressed in a gradient as early as 30% epiboly does not
necessarily mean that the BMP proteins are also expressed in a
gradient at that time. Indeed, post-transcriptional processing,
diffusion, transport and other regulatory mechanisms could result
in BMP protein expression differing from that of the bmp tran-
scripts. As no data are available for endogenous BMP protein
expression during early stages of zebraﬁsh development, we used
a new commercial zebraﬁsh speciﬁc BMP2B antibody to visualise
BMP2B protein expression.
Analysis of BMP2B protein expression revealed a graded stain-
ing pattern at all stages examined, from 30% to 75% epiboly
(Fig. 5A and data not shown). At 30% epiboly, strong BMP2B
protein expression is detected on one side of the embryo, while
BMP2B protein levels are much lower on the opposite side. At 60–
70% epiboly, a clear gradient of BMP2B protein expression is
detected in both the mesoderm and ectoderm. To conﬁrm that
the enrichment of BMP2B protein is indeed ventral, we compared
BMP2B with pMAPK expression and found that strong BMP2B and
pMAPK staining was obtained on opposite sides of the embryo at
30% epiboly (Fig. S4A). Using combined ISH for the dorsal marker
chordin and IF for BMP2B, it was also evident that BMP2B proteins
are enriched ventrally and expressed in a gradient during gastru-
lation (Fig. S4B). Close analysis of wild-type embryos injected with
membrane mRFP mRNA revealed that the BMP2B protein is
expressed in punctate cytoplasmic structures (Fig. S4C). Since the
antibody used was raised against the prodomain region of zebra-
ﬁsh BMP2B (Tebu-Bio/Anaspec, personal communication), it is
expected to detect pre-processed BMP2B. As a further check for
speciﬁcity we performed IF in embryos overexpressing BMP2B and
the nuclear marker Cherry H2B in a mosaic fashion and found that
increased BMP2B immunoreactivity correlates with cells over-
expressing BMP2B/Cherry H2B (Fig. S4D). We also injected
embryos with a translation blocking bmp2b MO (Imai and Talbot,2001) and examined BMP2B expression in the blastoderm at the
30% epiboly stage. BMP2B expression was reduced in the majority
of the bmp2b morphants compared with controls (Fig. 5B).
We have shown at 40% epiboly that the gradient of bmp2b
mRNA expression matches the BMP activity gradient read out by
mRFP mRNA (Fig. 4B). In contrast to what has been reported for
Dpp in the Drosophila wing (Entchev et al., 2000; Gibson et al.,
2002; Teleman and Cohen, 2000), this result strongly suggests that
active BMP ligands do not diffuse signiﬁcantly beyond the cells
that synthesise them in the zebraﬁsh embryo. Our ability to detect
both an endogenous BMP protein and BMP transcriptional activity
in the same embryo allowed us to determine whether transcrip-
tional activity can be detected at a distance from BMP protein
expressing cells. Using combined ISH for mRFP with IF for BMP2B
in 40% and 70% epiboly BRE-mRFP embryos, we found that the
expression of mRFP mRNA and BMP2B protein strongly overlap
(Fig. 5C). Our antibody detects pre-processed BMP2B, and in
principle, processed mature BMP2B, which we cannot detect,
may diffuse further than the BMP2B-expressing cells. However,
the fact that we do not detect any BMP transcriptional activity
(mRFP) beyond cells expressing BMP2B suggests that processed
BMP2B is not signiﬁcantly diffusible.
For the ﬁrst time therefore, we have shown the protein
expression pattern of an endogenous BMP ligand in zebraﬁsh.
BMP2B protein is expressed in a ventral to dorsal gradient in the
early zebraﬁsh embryo, which recapitulates both the bmp2bmRNA
expression, and the activity gradient read out by the mRFP
reporter. Thus, taken together, our results provide no evidence
that extensive diffusion of BMP2B protein occurs to generate the
BMP transcriptional activity gradient detected with mRFP.
Graded bmp ligand transcription, established by dharma and FGF
signalling and maintained through auto-regulation, determines the
BMP activity gradient
Since we have shown that graded bmp transcription precedes
the formation of the BMP activity gradient, we next investigated
how graded bmp transcription is established. Transcription of the
BMP ligands is known to be under autoregulation from about 60%
epiboly (Kishimoto et al., 1997; Nguyen et al., 1998; Schmid et al.,
2000). However, this does not appear to occur during blastula
stages (Furthauer et al., 2004). To inhibit BMP signalling during
blastula stages, we used LDN-193189 treatment from the 8–16 cell
stage onwards (Fig. S3) (Cannon et al., 2010) and found that most
embryos still retained graded bmp2b transcript expression at 30%
epiboly (Fig. 6A), despite a clear effect on overall transcript levels,
probably due to reduced maternal BMP signalling. This result
demonstrates that graded bmp2b transcription at 30% epiboly is
not dependent on zygotic BMP activity. Consistent with this view,
Chordin knockdown, which should lead to increased BMP signal-
ling, did not result in expanded bmp2b expression at 30% epiboly
(Fig. 6B) (Furthauer et al., 2004).
Having ruled out positive feedback by autocrine BMP signalling
as important for establishing graded bmp2b expression at 30%
epiboly, we tested the involvement of Dharma and FGF signalling
(Furthauer et al., 2004; Koos and Ho, 1999; Leung et al., 2003). The
lack of bmp2b and bmp7a transcripts dorsally at dome stage is a
strong indication of localised transcriptional repression by Dharma
(Fig. 4A), and this was conﬁrmed by the observation that injection
of a dharma MO resulted in expanded bmp2b transcription at 30%
epiboly in the majority of embryos examined (Fig. 6B). Notably, we
found that ectopic bmp2b is only detected at the margin, where
Dharma is expressed (Fig. 4A), but not in the dorsal ectoderm (see
white dotted lines in Fig. 6B). Consistent with dorsal bmp2b being
detected upon Dharma knockdown, we found that dharma mor-
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Fig. 5. Graded expression of endogenous BMP2B protein results in graded transcriptional activity. (A) IF for BMP2B in wild-type embryos. (B) IF for BMP2B in control and
bmp2b morphants. (C) Combined IF for BMP2B and ISH for mRFP in BRE-mRFP embryos. Note that there is some background staining for BMP2B that is due to
autoﬂuorescence from the yolk. Stages and views are indicated. The ﬂuorescent substrate used for mRFP in (C) was Cy5 tyramide (pseudocoloured in red). In (A) and
(C, bottom row), the pictures are the projection of a 25–30 stack of images taken from the edge of the embryo until about half way. In (B) and (C, top row), only the
blastoderm margin was imaged. The white dotted line in (C, bottom row) shows the outline of the embryo. V, ventral; D, dorsal.
M.-C. Ramel, C.S. Hill / Developmental Biology 378 (2013) 170–182178in 40% epiboly embryos (Fig. 6C). Expression of pMAPK at dome
and 30% epiboly stages indicates active FGF signalling in a dorsal to
ventral gradient, with stronger activity occurring at dome stage
(Fig. 4A). Using the FGF receptor inhibitor SU5402 (Mohammadi
et al., 1997), we demonstrated that FGF signalling inhibition results
in expansion of the domain of bmp2b expression to the dorsal side
at 30% epiboly (Fig. 6A) (Furthauer et al., 2004). Interestingly,
SU5402 treatment also results in reduced chordin expression at
this stage (Fig. S5). Thus, Dharma and FGF signalling are the critical
factors for establishing the graded bmp transcription that is
present at 30% epiboly, rather than auto-regulation via BMP
signalling.Chronologically, it is generally assumed that activity gradients
are established as a direct consequence of morphogen diffusion/
transport and that therefore these gradients are formed de novo.
However, our mRFP ISH results show that BMP activity in blastula
stage embryos is initially ubiquitous, then graded (Fig. 3). Hence
there must be a molecular mechanism that results in clearance of
mRFP transcripts dorsally (Fig. 6D). Indeed, our data indicate that
at 40% epiboly, when the gradient of BMP activity is established, it
faithfully reﬂects the gradient of BMP ligand transcription (Fig. 4B).
However, our mRFP ISHs and p-Smad1/5 staining indicates that
BMP activity is initially ubiquitous and is cleared from the dorsal
side between 30% and 40% epiboly (Fig. 3) (Tucker et al., 2008).
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M.-C. Ramel, C.S. Hill / Developmental Biology 378 (2013) 170–182 179This occurs after the bmp transcripts disappear dorsally, suggesting
that this might occur at the level of BMP protein inhibition
(residual dorsal BMP protein), if BMP receptors act to constantly
monitor ligand levels. This inhibition of signalling is most likely
mediated by Chordin. To test this idea we knocked down Chordin
with a MO and investigated the effect on mRFPmRNA levels at 40%
epiboly when they are normally graded. We could clearly demon-
strate that in chordin morphants the BMP activity gradient was
abolished and mRFP expression was uniform (Fig. 6C). This occurs
despite the fact that auto-regulation of bmp2b transcription only
occurs after that stage (Fig. S6). We therefore conclude that
between 30% and 40% epiboly, expression of Chordin on the dorsal
side of the embryo must contribute to a loss of dorsal BMP activity,
and that after 40–50% epiboly the BMP activity gradient becomes
maintained by the gradient of ligand transcription.Discussion
Using ISH for mRFP in our BRE-mRFP transgenic line, which is a
highly sensitive reporter for BMP/GDF signalling, we can visualise
the dynamics of BMP signalling in early zebraﬁsh embryos. We
have shown that the BMP transcriptional activity gradient is
established by 40% epiboly and is preceded by graded expression
of BMP ligands (mRNA and protein). For the ﬁrst time, we are able
to detect the expression of an endogenous BMP protein, BMP2B,
and found that it is expressed in a gradient during blastula and
gastrula stages and that no extensive diffusion of BMP2B occurs to
generate transcriptional activity at a distance. Our analysis
strongly supports the notion that the BMP activity gradient in
zebraﬁsh occurs as a result of graded BMP expression and does not
ﬁt the classical models of gradient formation, where ligands
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M.-C. Ramel, C.S. Hill / Developmental Biology 378 (2013) 170–182180synthesised from a local source would diffuse away in order to
produce a signalling gradient.
A powerful tool to visualise BMP/GDF activity
We conﬁrmed using various experimental approaches that
mRFP expression in our BRE-mRFP transgenic ﬁsh is a faithful
readout of BMP/GDF activity. We found that mRFP ﬂuorescence is
only detected from early somitogenesis stages, which is most
likely due to insufﬁcient amounts of mRFP protein being produced.
A similar lack of ﬂuorescence at early stages has been reported for
other transgenic reporter lines such as the Wnt reporter line
TOPdGFP (Dorsky et al., 2002), the Hedgehog pathway reporter
line Gli-d:mCherry (Schwend et al., 2010) and the other zebraﬁsh
BMP reporter lines (Alexander et al., 2011; Collery and Link, 2011;
Laux et al., 2011). However, mRFP ISH in our strong BRE-mRFP lines
visualised with either colourimetric or ﬂuorescent substrates
provides an excellent method to detect highly dynamic BMP
transcriptional activity.
Timing and mechanisms of BMP activity gradient formation during
blastula stages
We found that the ventral to dorsal BMP activity gradient,
revealed with mRFP ISH, is set up by 40% epiboly during theblastula period. The appearance of this gradient is preceded by the
establishment of graded expression of BMP ligands which occurs
between dome stage and 30% epiboly, and graded pathway
activation read out by p-Smad1/5 levels occurs fractionally before
the appearance of the mRFP gradient.
Using our results, combined with those from other studies
(Furthauer et al., 2004; Langdon and Mullins, 2011; Maegawa
et al., 2006), we propose a model for BMP activity gradient
formation that features the temporal and spatial requirement for
speciﬁc signalling events (Fig. 7). First, immediately after MBT,
bmps are induced ubiquitously in the embryo. In contrast, the
various BMP antagonists are locally induced by maternal β-
catenin2 on the future dorsal side of the embryo. At dome stage,
Dharma acts dorsally to locally repress bmp2b transcription. This
symmetry-breaking event is followed by the action of FGF signal-
ling at around 30% epiboly, which appears to act in a dorsal to
ventral graded fashion to inhibit bmp ligand transcription in a
dose-dependent manner. It is not yet clear how FGF signalling
achieves this. As a result, by 30% epiboly, all three bmp transcripts
are expressed in a graded manner. However, at this stage, our
experiments suggest that there must be some residual BMP
protein present on the dorsal side and that the BMP protein
gradient lags behind the bmp transcript gradient (Fig. 6D). One
clear indication of residual dorsal BMP protein is that p-Smad1/5 is
still detected dorsally at 30% epiboly, albeit at slightly lower levels,
M.-C. Ramel, C.S. Hill / Developmental Biology 378 (2013) 170–182 181and that mRFP transcripts are also strongly detected there (Fig. 3).
Between 30% and 40% epiboly, inhibition of residual BMP protein
function dorsally, via Chordin, rapidly leads to reduction in
p-Smad1/5 levels and the disappearance of mRFP transcripts.
Coupled with fast mRFP mRNA turnover, this contributes to the
detection of the BMP transcriptional activity gradient at 40%
epiboly. Interestingly, the rapid clearance of mRFP transcripts
dorsally and the fact that Chordin knockdown inhibits this, suggest
that BMP receptors must be able to monitor ligand activity at the
cell surface and thus respond to rapid changes in signalling. We
hypothesise that from 40% to 50% epiboly onwards, the BMP
activity gradient becomes proportional to the amount of BMP
transcripts and proteins, the expression of which is maintained
through auto-regulation, combined with pathway inhibition by
dorsally-expressed Chordin (Fig. 7; Fig. S6). One important feature
of this model is that there is a complex level of interaction
between all the molecular players. One example is that Chordin
expression in the blastula is partially under the control of FGF and
Nodal signaling (Fig. S5) and that optimal repression of bmp2b
expression by FGF signalling also appears to require Chordin
function (Maegawa et al., 2006).
The zebraﬁsh ventral to dorsal BMP activity gradient: An alternative
model for the formation of BMP gradients
BMPs have long been assumed to be morphogens in the
classical sense; that is that they are expressed from a local source
and diffuse in the extracellular space to generate an activity
gradient that is proportional to the amount of extracellular
proteins. Not only is the issue of BMP extracellular diffusion still
questionable, but the ways in which the activity gradients are
formed in various developmental systems also show that the BMP
signalling activity does not necessarily correlate with the amount
of signalling BMP proteins (Wolpert, 2011).
Our understanding of how BMP gradients ﬁrst form comes
predominantly from studies in Drosophila, where two different
mechanisms have been uncovered (reviewed by Ramel and Hill,
2012). To generate the Dpp activity gradient that determines A/P
patterning of the Drosophila wing, the Dpp ligand is secreted from
a central stripe of cells in the wing imaginal disc and acts at a
distance to form a concentration gradient both anteriorly and
posteriorly (Kicheva and Gonzalez-Gaitan, 2008; Raftery and
Umulis, 2012). In contrast, the D/V Dpp activity gradient that
forms in the embryonic Drosophila blastoderm results from redis-
tribution of ligand within a uniform dpp expression domain. This is
achieved by binding and transport of Dpp and a related ligand
Screw with the ligand antagonists Twisted Gastrulation and Short
Gastrulation (Drosophila Chordin) (O'Connor et al., 2006). An
analogous ligand shuttling mechanismwas proposed to be respon-
sible for the D/V BMP activity gradient in Xenopus, and was
preferred over an alternative inhibition-based mechanism where
an inhibition gradient of diffusible inhibitors like Chordin is
created over a uniform ﬁeld of activators (Ben-Zvi et al., 2008).
However, there is little evidence for this mechanism in the
Xenopus embryo and this issue is very controversial (Francois
et al., 2009).
We have shown that the early D/V BMP activity gradient is
formed in a very different manner in zebraﬁsh. Our study
demonstrates that the BMP activity gradient is actually created
in a tissue where activity is initially ubiquitous. Therefore this
particular gradient is not created de novo. We also found that the
control of BMP ligand transcription is the crucial determinant for
generating a BMP activity gradient that is robust and sustainable -
rather than extensive diffusion or redistribution of BMP proteins.
Indeed, consistent with published data on the diffusion of BMP4 in
Xenopus (Jones et al., 1996) and cell transplantation experiments inzebraﬁsh (Nikaido et al., 1999), we ﬁnd no evidence that zebraﬁsh
BMP proteins diffuse to generate signalling activity at a distance.
Our data highlights the fact that each BMP gradient is unique in
the way it is established and maintained.Acknowledgements
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